MBX Biosciences Inc. Comm...

NASDAQ: MBX · Real-Time Price · USD
14.74
1.53 (11.58%)
At close: Aug 15, 2025, 3:59 PM
14.92
1.22%
After-hours: Aug 15, 2025, 07:58 PM EDT

MBX Biosciences Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Cash & Equivalents
39.78M 29.9M 49.35M 132.87M 12.5M 35.42M 30.52M
Short-Term Investments
185.13M 210.88M 212.8M 144.2M 42.76M 34.89M 50.15M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
51K 50K 50K 50K 2.8M 1.74M 50K
Receivables
841K 1.39M 682K 858K 164K 199K 208K
Inventory
n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
3.44M 626K 803K 838K 242K 168K 133K
Total Current Assets
229.19M 244.28M 267.29M 281.17M 58.8M 72.7M 83.47M
Property-Plant & Equipment
2.28M 1.6M 1.2M 1.18M 1.28M 880K 665K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
2.33M 1.65M 1.25M 1.23M 4.08M 2.62M 715K
Total Assets
231.52M 245.93M 268.54M 282.4M 62.88M 75.32M 84.18M
Account Payables
5.76M 4.25M 5.33M 5M 3.22M 3.2M 1.39M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
138K 130K 171K 166K 162K 157K 153K
Other Current Liabilities
3.71M 1.1M 2.15M 1.68M 960K 1.57M 1.21M
Total Current Liabilities
11.76M 10.48M 11.05M 10.92M 8.2M 5.7M 3.93M
Long-Term Debt
512K n/a n/a 68K n/a 185K n/a
Other Long-Term Liabilities
15K 23K 42K n/a 152.48M n/a 152.55M
Total Long-Term Liabilities
527K 23K 42K 112K 152.57M 314K 152.72M
Total Liabilities
12.28M 10.5M 11.09M 11.03M 160.77M 6.01M 156.65M
Total Debt
650K 130K 171K 210K 249K 471K 324K
Common Stock
5K 5K 5K 5K 2K 1K 1K
Retained Earnings
-180.8M -161.38M -137.5M -121.92M -103.78M -87.92M -75.58M
Comprehensive Income
11K 53K 55K 106K -15K -3K 60K
Shareholders Equity
219.24M 235.42M 257.44M 271.37M -97.89M 69.31M -72.47M
Total Investments
185.13M 210.88M 212.8M 144.2M 42.76M 34.89M 50.15M